EVAN/ FA JONES
CIK 1020741 · Chief Executive Officer · last filed 2026-06-15
EVAN/ FA JONES is a Chief Executive Officer who has filed 122 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for VCYT, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$26.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions. 6 SEC filings were submitted jointly with jVen Capital, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.44M
8
122
-$26.72M
Filer Profile
SUITE 206
BELTSVILLE, MD 20705
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCYT | Director | 34,634 | $41.52 | $1.44M | -$12.88M | 42 | 2026-06-15 |
| OPGEN INC (OPGN) Delisted | Director | 222 | $24.75 | $5.5K | -$12.0K | 5 | 2021-05-19 |
| OPGEN INC (OPGNW) Delisted | Chief Executive Officer | 26,211 | — | — | $250.2K | 7 | 2019-11-13 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 26,952 | — | — | -$481.1K | 8 | 2017-12-15 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 58,551 | $3.71 | $217.2K | $75.6K | 20 | 2017-08-02 |
| OPGEN INC (OPGN.W) Delisted | Chief Executive Officer | 131,156 | — | — | $2.72M | 5 | 2016-05-23 |
| CAS MEDICAL SYSTEMS INC (CASM) Delisted | Director | 378,101 | — | — | $16.4K | 9 | 2013-07-02 |
| DIGENE CORP (DIGE) Delisted | Director | 0 | — | — | -$16.41M | 15 | 2007-07-30 |
Recent Filings
122 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | VCYT | Grant (A) | +5,272 | $0 | EDGAR |
| 2025-11-26 | VCYT | Sell (S) | −1,106 | -$55.6K | EDGAR |
| 2025-11-25 | VCYT | Notice (144) | −5,000 | -$246.9K | EDGAR |
| 2025-11-07 | VCYT | Mixed | −13,196 | -$1.74M | EDGAR |
| 2025-11-05 | VCYT | Notice (144) | −43,196 | -$1.99M | EDGAR |
| 2025-06-23 | VCYT | Grant (A) | +9,321 | $0 | EDGAR |
| 2024-09-23 | VCYT | Sell (S) | −5,173 | -$182.3K | EDGAR |
| 2024-08-14 | VCYT | Mixed | −39,359 | -$1.45M | EDGAR |
| 2024-08-13 | VCYT | Mixed | −1,478 | -$50.3K | EDGAR |
| 2024-08-13 | VCYT | Sell (S) | −5,108 | -$154.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.